Delivering babies is interesting from a pharmaceutical basis.
Care has to be taken in reducing the risk of side effects for both the mother and her baby. Most births will happen quite naturally, and without much (or even any) help. This is not always the case.
In about 20% of times a woman will need some help because the process is not occurring as fast as it should or the cervix is not opening up and letting the baby pass. In just over half of these women, the answer is to give a prostaglandin drug, like that found in the PropessŪ vaginal insert, to ripen the cervix and move the process along.
|
There are other drugs and products which will do this but ours has the key advantage of being retrievable. This means that the drug can be taken out quickly and remove any side effects which could be a problem. Nothing else can do this. This is the reason for our success.
|
|
Our hydrogel technology, formulated as a vaginal insert, offers an alternative means of ripening the cervix with sustained and controlled release of dinoprostone; additionally it increases the control available to the clinician. The resulting product is indicated for cervical ripening in cases where there is an obstetric or medical indication for the induction of labour.
The PropessŪ vaginal insert are the largest brand used in the obstetric field in the world. Every minute of every day a woman somewhere in the world will give birth assisted by one of our pessaries.
Launched in the US in 1995, the CervidilŪ/PropessŪ vaginal insert has subsequently been approved in over 50 countries, with the number of partners and distributors now around 16, the most significant of these being Forest Laboratories, who market the product under the name CervidilŪ in the US. In Europe, Ferring Pharmaceuticals markets the product under the name PropessŪ.
|
|
